NDRA (STOCKS)
ENDRA Life Sciences Inc. Common Stock
$4.470000
+0.000000 (+0.00%)
Prev close: $4.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Alexander Y. Tokman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6.07M
- Employees
- 16
- P/E (TTM)
- -0.55
- P/B (TTM)
- 3.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.80 | $-1.25 | -0.5454 | -43.47% |
|
Dec 2025 (Q4)
|
$-3.26 | $-1.25 | -2.0054 | -159.84% |
|
Sep 2025 (Q3)
|
$-2.10 | $-1.99 | -0.1110 | -5.58% |
|
Jun 2025 (Q2)
|
$-1.71 | $-2.32 | +0.6054 | +26.15% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$834.95K |
| Operating Expenses | $6.47M |
| Research and Development | $2.10M |
| Other Operating Expenses | $4.37M |
| Operating Income/Loss | -$6.47M |
| Income/Loss From Continuing Operations After Tax | -$7.30M |
| Income/Loss From Continuing Operations Before Tax | -$7.30M |
| Net Income/Loss | -$7.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.30M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.16 |
| Diluted Earnings Per Share | -$8.16 |
| Basic Average Shares | 1,429,024 |
| Diluted Average Shares | 1,429,024 |
| Assets | $3.44M |
| Current Assets | $536.67K |
| Prepaid Expenses | $180.20K |
| Other Current Assets | $356.46K |
| Noncurrent Assets | $2.90M |
| Fixed Assets | $33.02K |
| Other Non-current Assets | $2.87M |
| Liabilities | $1.65M |
| Current Liabilities | $835.44K |
| Accounts Payable | $456.84K |
| Other Current Liabilities | $378.60K |
| Noncurrent Liabilities | $815.86K |
| Equity | $1.79M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.79M |
| Liabilities And Equity | $3.44M |
| Net Cash Flow From Operating Activities | -$5.01M |
| Net Cash Flow From Operating Activities, Continuing | -$5.01M |
| Net Cash Flow From Investing Activities | -$2.55M |
| Net Cash Flow From Investing Activities, Continuing | -$2.55M |
| Net Cash Flow From Financing Activities | $5.85M |
| Net Cash Flow From Financing Activities, Continuing | $5.85M |
| Net Cash Flow | -$1.71M |
| Net Cash Flow, Continuing | -$1.71M |
| Comprehensive Income/Loss | -$7.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.30M |
| Other Comprehensive Income/Loss | $0.00 |